[Clinical Characteristics of 34 Adult Patients with Acute Leukemias of Ambiguous Lineage]

Overview

Journal Zhonghua Xue Ye Xue Za Zhi

Specialty Hematology

Date 2024 Jan 7

PMID 38185525

Authors

C X Pei

Q Zhan

C N Liu

W Peng

L Wang

L Liu

Y J Li

Y Liao

X H Luo

Affiliations

Soon will be listed here.

References

Huang J, Zhou J, Xiao M, Mao X, Zhu L, Liu S . The association of complex genetic background with the prognosis of acute leukemia with ambiguous lineage. Sci Rep. 2021; 11(1):24290. PMC: 8692450. DOI: 10.1038/s41598-021-03709-7. View

DeAngelo D, Stock W, Stein A, Shustov A, Liedtke M, Schiffer C . Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study. Blood Adv. 2018; 1(15):1167-1180. PMC: 5728308. DOI: 10.1182/bloodadvances.2016001925. View

Andrews C, Lam W, Sibai H . The successful use of inhibitors in -positive mixed phenotype acute leukemia. Leuk Lymphoma. 2020; 61(13):3275-3277. DOI: 10.1080/10428194.2020.1802451. View

Lazzarotto D, Tanasi I, Vitale A, Piccini M, DArgenio M, Giglio F . Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell.... Ann Hematol. 2023; 102(5):1099-1109. DOI: 10.1007/s00277-023-05162-0. View

Alexander T, Gu Z, Iacobucci I, Dickerson K, Choi J, Xu B . The genetic basis and cell of origin of mixed phenotype acute leukaemia. Nature. 2018; 562(7727):373-379. PMC: 6195459. DOI: 10.1038/s41586-018-0436-0. View

Pomerantz A, Rodriguez-Rodriguez S, Demichelis-Gomez R, Barrera-Lumbreras G, Barrales-Benitez O, Lopez-Karpovitch X . Mixed-phenotype acute leukemia: suboptimal treatment when the 2008/2016 WHO classification is used. Blood Res. 2017; 51(4):233-241. PMC: 5234234. DOI: 10.5045/br.2016.51.4.233. View

Quesada A, Hu Z, Routbort M, Patel K, Luthra R, Loghavi S . Mixed phenotype acute leukemia contains heterogeneous genetic mutations by next-generation sequencing. Oncotarget. 2018; 9(9):8441-8449. PMC: 5823573. DOI: 10.18632/oncotarget.23878. View

Montefiori L, Mullighan C . Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage. Best Pract Res Clin Haematol. 2021; 34(4):101329. PMC: 8649174. DOI: 10.1016/j.beha.2021.101329. View

Gupta M, Monga L, Mehrotra D, Chhabra S, Singhal S, Sen R . --Immunophenotypic Aberrancies in Acute Leukemia: A Tertiary Care Centre Experience. Oman Med J. 2021; 36(1):e218. PMC: 7874438. DOI: 10.5001/omj.2021.03. View

10.

Bene M, Castoldi G, Knapp W, Ludwig W, Matutes E, Orfao A . Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia. 1995; 9(10):1783-6. View

11.

Khoury J, Solary E, Abla O, Akkari Y, Alaggio R, Apperley J . The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022; 36(7):1703-1719. PMC: 9252913. DOI: 10.1038/s41375-022-01613-1. View

12.

Wolach O, Stone R . How I treat mixed-phenotype acute leukemia. Blood. 2015; 125(16):2477-85. DOI: 10.1182/blood-2014-10-551465. View

13.

Li M, Lin Z, Hu M, Kang L, Wu X, Chen Q . Secondary donor-derived humanized CD19-modified CAR-T cells induce remission in relapsed/refractory mixed phenotype acute leukemia after allogeneic hematopoietic stem cell transplantation: a case report. Biomark Res. 2020; 8:36. PMC: 7457525. DOI: 10.1186/s40364-020-00216-1. View

14.

Klocke H, Dong Z, OBrien C, Burwick N, Richard R, Wu D . Venetoclax and Decitabine for T/Myeloid Mixed-Phenotype Acute Leukemia Not Otherwise Specified (MPAL NOS). Case Rep Hematol. 2020; 2020:8811673. PMC: 7569429. DOI: 10.1155/2020/8811673. View

15.

. Multiparameter Flow Cytometry Applications in the Diagnosis of Mixed Phenotype Acute Leukemia (MPAL). Cytometry B Clin Cytom. 2019; 96(4):323. DOI: 10.1002/cyto.b.21835. View

16.

Ding L, Ley T, Larson D, Miller C, Koboldt D, Welch J . Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing. Nature. 2012; 481(7382):506-10. PMC: 3267864. DOI: 10.1038/nature10738. View

17.

Roberts K, Li Y, Payne-Turner D, Harvey R, Yang Y, Pei D . Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia. N Engl J Med. 2014; 371(11):1005-15. PMC: 4191900. DOI: 10.1056/NEJMoa1403088. View